Companies founded on innovation and strong science
Calluna Pharma
Our portfolio company, Arxx Therapeutics, merged with Oxitope Pharma in 2024 to form Calluna Pharma, a clinical stage company pioneering a breakthrough approach to treating inflammatory and fibrotic diseases by leveraging the body’s innate immune system.
Calluna Pharma
Sector:
Biotechnology
Country:
Norway/Netherlands
Year of first investment:
2019
Status:
Active
Website:
callunapharma.com
Other investments
